3 Top Stocks That’ll Make You Richer in July (and Beyond)

Congratulations, folks, we’ve made it to the halfway point of 2021, and things are beginning to look up. Two of the three major U.S. stock indexes hit an all-time high last week, and U.S. vaccination rates continue to head higher, signaling that an end to the pandemic, at least within the borders of the U.S., may be in sight…

Yet, even with equities pricier than they’ve seemingly been in close to two decades, value abounds for long-term investors. As we head into July, the following three top stocks stand out as particularly attractive, and they have a genuine shot at making investors richer this month, and well beyond.

Teladoc Health

To begin with, leading telehealth services provider Teladoc Health (NYSE:TDOC) looks like a bargain for growth seekers after losing nearly half of its value since mid-February.

If there’s a knock against Teladoc Health, it’s that there are questions about the company’s growth sustainability once we move beyond the pandemic. This is to say that Teladoc was served up on a silver platter in 2020. With physicians purposefully keeping high-risk patients out of their offices last year, many turned to virtual visits as a solution. As a result, the company handled 10.59 million total visits, up from 4.14 million in 2019.

While these growth concerns could prove palpable in the extremely short-term when life does return to some semblance of normal, the proof is in the pudding that telehealth services are a game-changer and here to stay. Being able to consult with a physician from home is substantially more convenient for patients. On the flipside, physicians should have easier access to vital health metrics for chronically ill patients with telemedicine services. The expectation is this’ll lead to improved patient outcomes, which means less money coming out of the pockets of health insurers.

The icing on the cake is that Teladoc grew its annual sales by an average of 74% in the six years leading up to the coronavirus pandemic. Again, despite post-pandemic growth concerns, both the logic of telehealth and the sales data demonstrate that it’s a driving force of change within the healthcare industry.

What’s more, Teladoc added an important puzzle piece in the fourth quarter of 2020 with the acquisition of applied health signals company Livongo Health. Livongo collects large amounts of data on patients with chronic illnesses, and with the help of artificial intelligence sends tips to its members to help them lead healthier lives. It had 658,000 diabetes members at the end of March, but is expanding its reach to include folks with hypertension and weight management issues. This means Livongo’s services will cover a large swath of the U.S. adult population.

Teladoc and Livongo are just scratching the surface of their potential as a broad-based personalized healthcare service. This could well be one of a handful of transformative healthcare companies of the decade.

Columbia Care

Another smart place to consider putting your money to work right now is in the cannabis industry. Understand, though, that the pot industry is bifurcated, with Canada largely underperforming and U.S. marijuana stocks outperforming. Since the U.S. is the largest cannabis market in the world by a longshot, one of the top stocks to consider buying right now is under-the-radar U.S. multistate operator (MSO) Columbia Care (OTC:CCHWF).

Although a lot of folks are waiting for the Biden administration to tackle cannabis reform, it’s simply not needed. While it’d be great if restrictions were lifted for U.S. pot stocks, the fact is that 36 states have legalized weed in some capacity, 11 of which are also currently selling adult-use cannabis in dispensaries. As long as the federal Justice Department allows states to regulate their own industries, this will be a high-growth opportunity for investors.

The interesting thing about the lesser-known Columbia Care is that…

Continue reading at THE MOTLEY FOOL


Leave a Reply

Your email address will not be published.